These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24289537)

  • 1. Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice.
    Tanaka S; Ishii A; Ohtaki H; Shioda S; Yoshida T; Numazawa S
    J Neuroinflammation; 2013 Dec; 10():143. PubMed ID: 24289537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
    De Lella Ezcurra AL; Chertoff M; Ferrari C; Graciarena M; Pitossi F
    Neurobiol Dis; 2010 Mar; 37(3):630-40. PubMed ID: 19969084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
    George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
    Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.
    Qin L; Wu X; Block ML; Liu Y; Breese GR; Hong JS; Knapp DJ; Crews FT
    Glia; 2007 Apr; 55(5):453-62. PubMed ID: 17203472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
    Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation.
    Couch Y; Alvarez-Erviti L; Sibson NR; Wood MJ; Anthony DC
    J Neuroinflammation; 2011 Nov; 8():166. PubMed ID: 22122884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglial activation, interleukin-1beta, and expression of caspase-11 in mice.
    Arai H; Furuya T; Yasuda T; Miura M; Mizuno Y; Mochizuki H
    J Biol Chem; 2004 Dec; 279(49):51647-53. PubMed ID: 15383538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms.
    Fu SP; Wang JF; Xue WJ; Liu HM; Liu BR; Zeng YL; Li SN; Huang BX; Lv QK; Wang W; Liu JX
    J Neuroinflammation; 2015 Jan; 12():9. PubMed ID: 25595674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
    Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
    Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration.
    Qin L; Liu Y; Hong JS; Crews FT
    Glia; 2013 Jun; 61(6):855-68. PubMed ID: 23536230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.
    Niu H; Wang Q; Zhao W; Liu J; Wang D; Muhammad B; Liu X; Quan N; Zhang H; Zhang F; Wang Y; Li H; Yang R
    Brain Pathol; 2020 Nov; 30(6):1102-1118. PubMed ID: 32678959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the lipopolysaccharide induced model of Parkinson's disease: Role of oxidative stress and neuroinflammation.
    Sharma N; Nehru B
    Neurochem Int; 2015 Aug; 87():92-105. PubMed ID: 26055970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
    Kuter KZ; Śmiałowska M; Ossowska K
    Pharmacol Rep; 2022 Feb; 74(1):67-83. PubMed ID: 34762280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of IL-6R Expression on IL-6/STAT3/HIF-1α Signaling Pathway in a Mouse Model of Parkinson's Disease with Type 2 Diabetes Co-Morbidity.
    Hu A; She Y; Wang Y; Cao X; Li R; Wang J; Yu L; Jiang H; Zhao Y
    Discov Med; 2024 Jul; 36(186):1386-1397. PubMed ID: 39054710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of interleukin-1 in lipopolysaccaride-induced microglial activation and learning and memory deficits.
    Tanaka S; Kondo H; Kanda K; Ashino T; Nakamachi T; Sekikawa K; Iwakura Y; Shioda S; Numazawa S; Yoshida T
    J Neurosci Res; 2011 Apr; 89(4):506-14. PubMed ID: 21290410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erinacine A Prevents Lipopolysaccharide-Mediated Glial Cell Activation to Protect Dopaminergic Neurons against Inflammatory Factor-Induced Cell Death In Vitro and In Vivo.
    Lee SL; Hsu JY; Chen TC; Huang CC; Wu TY; Chin TY
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054997
    [No Abstract]   [Full Text] [Related]  

  • 19. Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease.
    Gorelenkova Miller O; Behring JB; Siedlak SL; Jiang S; Matsui R; Bachschmid MM; Zhu X; Mieyal JJ
    Antioxid Redox Signal; 2016 Dec; 25(18):967-982. PubMed ID: 27224303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of endotoxin tolerance on peripheral lipopolysaccharide-induced neuroinflammation and dopaminergic neuronal injury.
    Yao L; Li P; Chen Q; Hu A; Wu Y; Li B
    Immunopharmacol Immunotoxicol; 2022 Jun; 44(3):326-337. PubMed ID: 35260024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.